TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
ANIX

Anixa Biosciences Inc

Healthcare · Biotechnology

2.90$ +2.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Anixa Biosciences Inc (ANIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 15 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANIX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
26 25 24 23 22 19 17 18 16 15 15 15
25 25 24 23 21 19 17 17 16 15 15 15
0.9 1.0 1.0 1.2 1.3 1.1 1.9 1.5 1.2 1.5 1.5 1.4
24 24 23 21 20 17 16 16 15 14 14 14
0.3 0.4 0.2 0.4 0.2 0.0 0.0 0.0 0.0 – 0.1 –
2.2 1.8 1.8 2.2 2.7 2.2 2.1 2.2 2.1 1.4 1.6 1.9
2.0 1.7 1.7 2.0 2.5 2.0 1.9 2.1 2.0 1.2 1.5 1.7
0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.2 0.4 0.2 0.3 0.5 0.6 0.3 0.3 0.2 0.1 0.3 0.3
24 25 24 22 20 18 16 17 15 15 14 14
-228 -231 -235 -238 -241 -244 -247 -249 -252 -254 -257 -259
31 31 32 32 32 32 32 32 32 33 34 34

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?